Xlife Sciences focuses on the performance and growth of life science technologies.
Xlife Sciences AG has raised $5.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2022.
Xlife Sciences AG is headquartered in Zürich, Switzerland.
Xlife Sciences focuses on the performance and growth of life science technologies.
Xlife Sciences AG is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xlife Sciences AG — Funding & Investors." VCBacked, January 26, 2022, https://www.vcbacked.co/company/xlife-sciences-ag. Accessed November 13, 2026.
VCBacked. (2022). Xlife Sciences AG — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/xlife-sciences-ag
{{cite web |title=Xlife Sciences AG — Funding & Investors |url=https://www.vcbacked.co/company/xlife-sciences-ag |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Xlife Sciences AG? Request a listing update